Program on an FDA Approved Treatment Option
YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM
A program on an FDA approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.
Nazy Zomorodian, MSN, CUNP, CCRC
Director, Clinical Trials Program
Board Certified Urology Nurse Practitioner
UCLA Institute of Urologic Oncology
Los Angeles, CA
Kindly Reply by
June 16, 2020
In the RSVP, please include your Name, Contact
Information, Organization, and Specialty.